Migraine Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 15 and 69 years old.
- You have been diagnosed with migraine by a neurologist who specialises in headaches, using established international guidelines.
- You have had migraines for at least 1 year.
- Your neurological examination (a check of your nervous system) came back normal.
- You are willing and able to give your consent to take part in the study.
- You are able to describe your own symptoms and headache patterns clearly.
- You have had an average of 10 to 14 migraine days per month over the last three months.
- You are comfortable using a smartphone at a basic level.
- You are able to attend and complete two months of follow-up as part of the study.
Who may not be able to join:
- You have another type of headache (other than headaches caused by overusing pain medication).
- You have a cognitive (thinking or memory) difficulty or another condition that could make it hard to take part properly in the study.
- Your neurological examination showed any abnormal findings (confirm with trial site).
- You are currently pregnant or breastfeeding.
- You have a known heart condition, lung condition, Sjögren's syndrome, diabetes, or a thyroid condition (either overactive or underactive).
- You have a pacemaker, a nerve stimulator, or any other electronic device implanted in your body that could interfere with the study's measurements.
- You have a physical feature that would make it impossible to use the study's wearable device (confirm with trial site).
- It is expected that your migraine prevention medication or other regular treatments may need to be changed during the study period.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ana Beatriz Gago Veiga, Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Phone: +34 915202416
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Development of a prediction strategy for the onset of migraine
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.